Daniel Y. Wang, MD

Immune Checkpoint Inhibitor Therapy in Patients With Autoimmune Disease

Douglas B. Johnson, MD, MSCI
Kathryn E. Beckermann, MD, PhD
Daniel Y. Wang, MD

Apr 15, 2018

In this article, we detail the experience with immune checkpoint inhibitors in patients with autoimmune disease.

Combination Immunotherapy: An Emerging Paradigm in Cancer Therapeutics

Daniel Y. Wang, MD
Jeffrey A. Sosman, MD
Douglas B. Johnson, MD, MSCI

Dec 16, 2015

In view of the potential for durable responses with immunotherapy, it will be important to identify the most effective and least toxic regimens for individual patients.